Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Sprowl

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Hearing Research|June 27, 2026
Slc16a5 (MCT6) knockout induces sex-dependent changes in auditory function, hair cell viability and cochlear transcriptomic programs in the mouseArthur Germakovski, Mengxiao Ye, Guang-Di Chen, et al.
Pharmacological Reviews|February 21, 2026
Role of solute carrier transporters in the biodistribution and toxicity of chemotherapeutic drugsMike Boeckman, Thomas Drabison, Arthur Germakovski, et al.
Breast Cancer Research : BCR|January 10, 2012
Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: a study in isogenic resistant tumor cellsJason A Sprowl, Kerry Reed, Stephen R Armstrong, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 19, 2013
Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2Jason A Sprowl, Giuliano Ciarimboli, Cynthia S Lancaster, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 3, 2025
Regulation of hepatic organic anion transporting polypeptide 1B-type transport function by the protein kinase LYNVivian Xu, Mahesh R Nepal, Eman Ahmed, et al.
Molecular Pharmacology|April 6, 2022
Influence of Tyrosine Kinase Inhibition on Organic Anion Transporting Polypeptide 1B3-Mediated UptakeVusumuzi N Hove, Kenneth Anderson, Elizabeth R Hayden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2014
Cisplatin-induced renal injury is independently mediated by OCT2 and p53Jason A Sprowl, Cynthia S Lancaster, Navjotsingh Pabla, et al.
Pharmacogenomics|April 1, 2015
Human OCT2 variant c.808G>T confers protection effect against cisplatin-induced ototoxicityClaudia Lanvers-Kaminsky, Jason A Sprowl, Ingrid Malath, et al.
Clinical Pharmacology and Therapeutics|May 15, 2018
Disease-Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter ConsortiumRaymond Evers, Micheline Piquette-Miller, Joseph W Polli, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2015
Mitigation of acute kidney injury by cell-cycle inhibitors that suppress both CDK4/6 and OCT2 functionsNavjotsingh Pabla, Alice A Gibson, Mike Buege, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Hearing Research|June 27, 2026
Slc16a5 (MCT6) knockout induces sex-dependent changes in auditory function, hair cell viability and cochlear transcriptomic programs in the mouseArthur Germakovski, Mengxiao Ye, Guang-Di Chen, et al.
Pharmacological Reviews|February 21, 2026
Role of solute carrier transporters in the biodistribution and toxicity of chemotherapeutic drugsMike Boeckman, Thomas Drabison, Arthur Germakovski, et al.
Breast Cancer Research : BCR|January 10, 2012
Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: a study in isogenic resistant tumor cellsJason A Sprowl, Kerry Reed, Stephen R Armstrong, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 19, 2013
Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2Jason A Sprowl, Giuliano Ciarimboli, Cynthia S Lancaster, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 3, 2025
Regulation of hepatic organic anion transporting polypeptide 1B-type transport function by the protein kinase LYNVivian Xu, Mahesh R Nepal, Eman Ahmed, et al.
Molecular Pharmacology|April 6, 2022
Influence of Tyrosine Kinase Inhibition on Organic Anion Transporting Polypeptide 1B3-Mediated UptakeVusumuzi N Hove, Kenneth Anderson, Elizabeth R Hayden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2014
Cisplatin-induced renal injury is independently mediated by OCT2 and p53Jason A Sprowl, Cynthia S Lancaster, Navjotsingh Pabla, et al.
Pharmacogenomics|April 1, 2015
Human OCT2 variant c.808G>T confers protection effect against cisplatin-induced ototoxicityClaudia Lanvers-Kaminsky, Jason A Sprowl, Ingrid Malath, et al.
Clinical Pharmacology and Therapeutics|May 15, 2018
Disease-Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter ConsortiumRaymond Evers, Micheline Piquette-Miller, Joseph W Polli, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2015
Mitigation of acute kidney injury by cell-cycle inhibitors that suppress both CDK4/6 and OCT2 functionsNavjotsingh Pabla, Alice A Gibson, Mike Buege, et al.
Pageof 3